Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
8.20
+0.36 (4.59%)
At close: Mar 4, 2026, 4:00 PM EST
8.18
-0.02 (-0.24%)
Pre-market: Mar 5, 2026, 5:00 AM EST

Vanda Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
485521279243420877
Market Cap Growth
88.01%86.63%15.04%-42.14%-52.16%21.66%
Enterprise Value
233.46528.34287.4-138.46-38.41454.33
Last Close Price
8.208.824.794.227.3915.69
PE Ratio
--2.36-14.52105.5067.1827.05
Forward PE
----21.7421.94
PS Ratio
2.242.411.411.261.653.26
PB Ratio
1.481.590.520.450.801.74
P/TBV Ratio
1.481.590.520.450.801.77
P/FCF Ratio
--4.72-17.1919.5513.4013.78
P/OCF Ratio
--4.76-17.7318.9713.1213.66
EV/Sales Ratio
1.082.441.45-0.72-0.151.69
EV/EBITDA Ratio
--3.79-9.3114.40-4.2410.09
EV/EBIT Ratio
--3.50-7.079.92-6.0710.77
EV/FCF Ratio
--4.78-17.69-11.15-1.237.14
Debt / Equity Ratio
0.020.020.020.010.020.02
Debt / EBITDA Ratio
-0.05-0.05-0.26-0.730.970.22
Debt / FCF Ratio
-0.06-0.06-0.500.560.280.16
Net Debt / Equity Ratio
0.020.020.02-0.70-0.87-0.84
Net Debt / EBITDA Ratio
-0.05-0.05-0.2639.64-50.55-9.39
Net Debt / FCF Ratio
-0.06-0.06-0.50-30.70-14.63-6.64
Asset Turnover
0.940.940.440.300.410.48
Inventory Turnover
1.101.101.021.242.233.00
Quick Ratio
0.380.380.474.825.476.25
Current Ratio
0.470.470.584.945.686.43
Return on Equity (ROE)
-50.93%-50.93%-3.49%0.47%1.22%6.92%
Return on Assets (ROA)
-104.54%-104.54%-7.35%-0.86%0.57%5.85%
Return on Invested Capital (ROIC)
-136.39%-136.39%-15.01%-3.21%2.83%25.31%
Return on Capital Employed (ROCE)
-140.80%-140.80%-11.22%-2.53%1.19%8.54%
Earnings Yield
-45.49%-42.40%-6.89%0.95%1.49%3.70%
FCF Yield
-22.79%-21.19%-5.82%5.11%7.46%7.26%
Buyback Yield / Dilution
0.18%0.18%0.00%0.00%-0.17%-0.40%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q